STOCK TITAN

Rubicon Organics to Report Q2 2024 Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF), a licensed producer of organic certified and premium cannabis products, has announced it will report its Q2 2024 financial results on August 15, 2024, before the market opens. The company will host a conference call to discuss the results on the same day at 7:00 AM PT / 10:00 AM ET.

Investors and interested parties can join the conference call using the following details:

  • Conference ID: 28425
  • Local dial-in: +1 (289) 514 5100
  • Toll-Free N. America: +1 (800) 717 1738
A webcast of the call will also be available for those who prefer to listen online.

Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF), un produttore autorizzato di prodotti di cannabis organici certificati e premium, ha annunciato che riporterà i suoi risultati finanziari del Q2 2024 il 15 agosto 2024, prima dell'apertura del mercato. L'azienda ospiterà una conference call per discutere i risultati lo stesso giorno alle 7:00 AM PT / 10:00 AM ET.

Investitori e parti interessate possono unirsi alla conference call utilizzando i seguenti dettagli:

  • ID conferenza: 28425
  • Numero locale: +1 (289) 514 5100
  • Numero verde Nord America: +1 (800) 717 1738
Un webcast della chiamata sarà anche disponibile per coloro che preferiscono ascoltare online.

Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF), un productor autorizado de productos de cannabis orgánica certificada y premium, ha anunciado que reportará sus resultados financieros del Q2 2024 el 15 de agosto de 2024, antes de la apertura del mercado. La empresa llevará a cabo una llamada de conferencia para discutir los resultados el mismo día a las 7:00 AM PT / 10:00 AM ET.

Los inversionistas y partes interesadas pueden unirse a la llamada de conferencia utilizando los siguientes detalles:

  • ID de la conferencia: 28425
  • Llamada local: +1 (289) 514 5100
  • Número gratuito en América del Norte: +1 (800) 717 1738
También estará disponible una transmisión web de la llamada para aquellos que prefieren escuchar en línea.

루비콘 오르가닉스 주식회사 (TSXV: ROMJ) (OTCQX: ROMJF), 유기농 인증 및 프리미엄 대마초 제품의 라이센스 제조업체,는 2024년 2분기 재무 결과를 2024년 8월 15일, 시장 개장 전에 발표할 예정이라고 발표했습니다. 이 회사는 같은 날 오전 7:00 PT / 오전 10:00 ET에 결과 논의를 위해 컨퍼런스 콜을 주최할 것입니다.

투자자 및 관심 있는 사람들은 다음 세부정보를 사용하여 컨퍼런스 콜에 참가할 수 있습니다:

  • 컨퍼런스 ID: 28425
  • 지역 전화번호: +1 (289) 514 5100
  • 북미 무료 전화: +1 (800) 717 1738
온라인에서 듣기를 선호하는 사람들을 위해 전화회의의 웹캐스트도 제공될 것입니다.

Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF), un producteur agréé de produits de cannabis biologiques certifiés et haut de gamme, a annoncé qu'elle publiera ses résultats financiers du T2 2024 le 15 août 2024, avant l'ouverture du marché. L'entreprise tiendra une conférence téléphonique pour discuter des résultats le même jour à 7h00 PT / 10h00 ET.

Les investisseurs et les parties intéressées peuvent rejoindre la conférence téléphonique en utilisant les détails suivants :

  • ID de la conférence : 28425
  • Appel local : +1 (289) 514 5100
  • Numéro gratuit Amérique du Nord : +1 (800) 717 1738
Un webinaire de l'appel sera également disponible pour ceux qui préfèrent écouter en ligne.

Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF), ein lizenzierten Hersteller von organisch zertifizierten und Premium-Cannabisprodukten, hat angekündigt, dass es am 15. August 2024 vor der Markteröffnung seine Finanzergebnisse für Q2 2024 bekannt geben wird. Das Unternehmen wird am selben Tag um 7:00 AM PT / 10:00 AM ET eine Telefonkonferenz abhalten, um die Ergebnisse zu diskutieren.

Investoren und interessierte Parteien können sich mit den folgenden Einzelheiten zur Telefonkonferenz zusammenschalten:

  • Konferenz-ID: 28425
  • Ortsgespräch: +1 (289) 514 5100
  • Kostenlose Nummer Nordamerika: +1 (800) 717 1738
Eine Webcast der Konferenz wird ebenfalls für diejenigen verfügbar sein, die es vorziehen, online zuzuhören.

Positive
  • None.
Negative
  • None.

VANCOUVER, British Columbia, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) (“Rubicon Organics” or the “Company”), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, is pleased to announce that it will be reporting its financial results for the three and six months ended June 30, 2024 (“Q2 2024”) before market open on Thursday, August 15, 2024.

The Company will be hosting a conference call to discuss Q2 2024 results on Thursday, August 15, 2024. Conference call details are as follows:

Time:7:00 AM PT / 10:00 AM ET
Conference ID:28425
Local dial-in:        +1 (289) 514 5100
Toll Free N. America:+1 (800) 717 1738
Webcast:https://onlinexperiences.com/Launch/QReg/ShowUUID=998CDFC5-521F-481F-A060-E0B295AB46B5

ABOUT RUBICON ORGANICS INC.

Rubicon Organics Inc. is the global brand leader in premium organic cannabis products. The Company is vertically integrated through its wholly owned subsidiary Rubicon Holdings Corp, a licensed producer. Rubicon Organics is focused on achieving industry leading profitability through its premium cannabis flower, product innovation and brand portfolio management, including three flagship brands: its super-premium brand Simply Bare™ Organic, its premium brand 1964 Supply Co™, and its cannabis wellness brand Wildflower™ in addition to the Company’s mainstream brand Homestead Cannabis Supply™.

The Company ensures the quality of its supply chain by cultivating, processing, branding and selling organic certified, sustainably produced, super-premium cannabis products from its state-of-the-art glass roofed facility located in Delta, BC, Canada.

CONTACT INFORMATION

Margaret Brodie
CEO
Phone: +1 (437) 929-1964
Email: ir@rubiconorganics.com

The TSX Venture Exchange or its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) does not accept responsibility for the adequacy or accuracy of this press release.

Cautionary Statement Regarding Forward Looking Information

This press release contains forward-looking information within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, statements regarding Rubicon Organics’ goal of achieving industry leading profitability are “forward-looking statements”. Forward-looking information can be identified by the use of words such as “will” or variations of such word or statements that certain actions, events or results “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. The forward-looking information in this press release is based upon certain assumptions that management considers reasonable in the circumstances, the impact on revenue of new products and brands entering the market, and the timing of achieving Adjusted EBITDA profitability and cash flow positive. Risks and uncertainties associated with the forward looking information in this press release include, among others, dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing federal, provincial, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits for construction at its facilities in a timely manner; regulatory or political change such as changes in applicable laws and regulations, including bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; Rubicon Organics’ limited operating history and lack of historical profits; reliance on management; the effect of capital market conditions and other factors on capital availability; the Company’s ability to attract and retain skilled staff; competition, including from more established or better financed competitors; the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers.

These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although Rubicon Organics has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. Rubicon Organics assumes no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.


FAQ

When will Rubicon Organics (ROMJF) release its Q2 2024 financial results?

Rubicon Organics (ROMJF) will release its Q2 2024 financial results before market open on Thursday, August 15, 2024.

What time is the Rubicon Organics (ROMJF) Q2 2024 earnings conference call?

The Rubicon Organics (ROMJF) Q2 2024 earnings conference call is scheduled for Thursday, August 15, 2024, at 7:00 AM PT / 10:00 AM ET.

How can investors join the Rubicon Organics (ROMJF) Q2 2024 earnings call?

Investors can join the Rubicon Organics (ROMJF) Q2 2024 earnings call by dialing +1 (289) 514 5100 locally, or +1 (800) 717 1738 toll-free in North America, using the conference ID 28425. A webcast option is also available.

What period will Rubicon Organics' (ROMJF) Q2 2024 financial results cover?

Rubicon Organics' (ROMJF) Q2 2024 financial results will cover the three and six months ended June 30, 2024.

RUBICON ORGANICS INC

OTC:ROMJF

ROMJF Rankings

ROMJF Latest News

ROMJF Stock Data

15.29M
26.33M
53.52%
3.89%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Vancouver